Inventor · disambiguated record
Avinash Nangia
Also filed as: NANGIA AVINASH · NANGIA AVINASH K
29 granted patents·34 pending applications·392 citations·filing 1990–2022
96Inventor score
Files withSPHERICS INC9ANDRX PHARMACEUTICALS LLC8TOLMAR INTERNATIONAL LTD4WATSON PHARMACEUTICALS INC4ANDRX PHARMACEUTICALS INC3
Top patents by PatentIndex Score
63 records- 0197US6905708B2Controlled release oral dosage formANDRX PHARMACEUTICALS INC·Filed 2003·Granted Jun 14, 2005·76 cites·6 claims
- 0295US6589553B2Controlled release oral dosage formANDRX PHARMACEUTICALS INC·Filed 2001·Granted Jul 8, 2003·64 cites·8 claims
- 0384US8545880B2Controlled release oral dosage formLI BOYONG·Filed 2002·Granted Oct 1, 2013·13 cites·14 claims
- 0484US7314640B2Formulation and process for drug loaded coresSRIWONGJANYA MONGKOL·Filed 2003·Granted Jan 1, 2008·26 cites·37 claims
- 0584US5342627AControlled release deviceGLAXO CANADA·Filed 1992·Granted Aug 30, 1994·76 cites·15 claims
- 0682US7771750B2Controlled release oral dosage formANDRX PHARMACEUTICALS LLC·Filed 2005·Granted Aug 10, 2010·4 cites·11 claims
- 0780US8470368B2Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivativeKOSITPRAPA UNCHALEE·Filed 2011·Granted Jun 25, 2013·2 cites·18 claims
- 0879US7959946B2Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivativeWATSON PHARMACEUTICALS INC·Filed 2004·Granted Jun 14, 2011·7 cites·18 claims
- 0979US7476403B2Oral extended-release compositionANDRX PHARMACEUTICALS LLC·Filed 2004·Granted Jan 13, 2009·11 cites·15 claims
- 1078US8668931B2Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivativeWATSON PHARMACEUTICALS INC·Filed 2013·Granted Mar 11, 2014·1 cites·18 claims
- 1178US7790200B2Formulation and process for drug loaded coresANDRX PHARMACEUTICALS LLC·Filed 2007·Granted Sep 7, 2010·1 cites·7 claims
- 1277US9744137B2Topiramate compositions and methods of enhancing its bioavailabilityNANGIA AVINASH·Filed 2007·Granted Aug 29, 2017·6 cites·25 claims
- 1377US7237436B2Dosage form holder device and methods for immersion testingTIAN DACHENG·Filed 2006·Granted Jul 3, 2007·5 cites·14 claims
- 1475US7785627B2Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivativeWATSON PHARMACEUTICALS INC·Filed 2003·Granted Aug 31, 2010·8 cites·5 claims
- 1574US7470435B2Extended release venlafaxine formulationANDRX PHARMACEUTICALS LLC·Filed 2003·Granted Dec 30, 2008·3 cites·18 claims
- 1673US8084058B2Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivativeLODIN UNCHALEE·Filed 2005·Granted Dec 27, 2011·2 cites·4 claims
- 1770US7051606B2Dosage form holder device and methods for immersion testingANDRX LABS LLC·Filed 2004·Granted May 30, 2006·7 cites·11 claims
- 1869US7642286B2Stable pharmaceutical compositions containing pravastatinANDRX PHARMACEUTICALS INC·Filed 2002·Granted Jan 5, 2010·3 cites·3 claims
- 1968US2015072001A1Novel pharmaceutical formulation containing a biguanide and a thiazolidinedione derivativeWATSON PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 2067US8309125B2Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivativeKOSITPRAPA UNCHALEE·Filed 2010·Granted Nov 13, 2012·1 cites·7 claims
- 2165US7931915B2Extended release venlafaxine formulationANDRX PHARMACEUTICALS LLC·Filed 2008·Granted Apr 26, 2011·0 cites·10 claims
- 2264US7713550B2Controlled release sodium valproate formulationANDRX CORP·Filed 2004·Granted May 11, 2010·1 cites·3 claims
- 2364US2007237820A1Pharmaceutical formulations containing a non-steroidal antinflammatory drug and an antiulcerative drugANDRX PHARMACEUTICALS LLC·Filed 2007·Application pending·0 cites
- 2464US2022313772A1Method of Treating a Child with Central Precocious Puberty using an Extended Release CompositionTOLMAR INTERNATIONAL LTD·Filed 2022·Application pending·0 cites
- 2563US5196190ASynthetic skin substitutesZENITH TECHNOLOGY CORP LTD·Filed 1990·Granted Mar 23, 1993·75 cites·19 claims
- 2663US2007003621A1Dosage forms for movement disorder treatmentSPHERICS INC·Filed 2006·Application pending·0 cites
- 2763US2008299204A1Dosage forms for movement disorder treatmentSPHERICS INC·Filed 2006·Application pending·0 cites
- 2859US12453754B2Leuprolide acetate compositions and methods of using the same to treat breast cancerTOLMAR INTERNATIONAL LTD·Filed 2020·Granted Oct 28, 2025·0 cites·20 claims
- 2959US8668932B2Extended release venlafaxine formulationDIXIT MANESH·Filed 2011·Granted Mar 11, 2014·0 cites·14 claims
- 3057US8529946B2Rapidly disintegrating antihistamine formulationKOSITPRAPA UNCHALEE·Filed 2004·Granted Sep 10, 2013·0 cites·6 claims
- 3157US2005163847A1Pharmaceutical formulations containing a non-steroidal antiinflammatory drug and an antiulcerative drugANDRX PHARMACEUTICALS LLC·Filed 2005·Application pending·0 cites
- 3256US2021228477A1Methods and Kit for Treating Skin DisordersLUPIN ATLANTIS HOLDINGS SA·Filed 2021·Application pending·0 cites
- 3355US8747898B2Controlled release oral dosage formLI BOYONG·Filed 2010·Granted Jun 10, 2014·0 cites·11 claims
- 3455US8628797B2Oral extended-release compositionLI BOYING·Filed 2008·Granted Jan 14, 2014·0 cites·4 claims
- 3555US2005051922A1Pharmaceutical composition with sodium lauryl sulfate as an extra-granular absorption/compression enhancer and the process to make the sameFiled 2004·Application pending·0 cites
- 3655US2009292016A1Stable Pharmaceutical Compositions Containing PravastatinLI BOYONG·Filed 2009·Application pending·0 cites
- 3755US2008131492A1Dosage forms for movement disorder treatmentSPHERICS INC·Filed 2007·Application pending·0 cites
- 3854US2022040201A1Liquid polymer delivery system for extended administration of drugsTOLMAR INT LTD·Filed 2019·Application pending·0 cites
- 3954US2010226855A1Rate-Controlled Oral Dosage FormulationsSPHERICS INC·Filed 2007·Application pending·0 cites
- 4054US2010323010A1Formulation and process for drug loaded coresANDRX PHARMACEUTICALS LLC·Filed 2010·Application pending·0 cites
- 4154US2007209455A1Dosage form holder device and methods for immersion testingTIAN D·Filed 2007·Application pending·0 cites
- 4253US2022362383A1Liquid polymer compositions and systems for extended delivery of peptides as active pharmaceutical ingredientsTOLMAR INTERNATIONAL LTD·Filed 2020·Application pending·0 cites
- 4353US2007148238A1Dosage forms for movement disorder treatmentSPHERICS INC·Filed 2006·Application pending·0 cites
- 4452US2004043073A1Pharmaceutical compositions for drugs having pH-dependent solubilityFiled 2003·Application pending·0 cites
- 4552US2019224112A1Methods and Kit for Treating Skin DisordersLUPIN ATLANTIS HOLDINGS SA·Filed 2018·Application pending·0 cites
- 4652US2020330547A1Method of Treating a Child with Central Precocious Puberty using an Extended Release CompositionTOLMAR INTERNATIONAL LTD·Filed 2019·Application pending·0 cites
- 4750US2005201974A1Bioadhesive polymers with catechol functionalitySPHERICS INC·Filed 2004·Application pending·0 cites
- 4849US2005048119A1Controlled release composition with semi-permeable membrane and poloxamer flux enhancerFiled 2004·Application pending·0 cites
- 4949US2004166162A1Novel pharmaceutical formulation containing a proton pump inhibitor and an antacidFiled 2004·Application pending·0 cites
- 5049US2006045865A1Controlled regional oral deliverySPHERICS INC·Filed 2005·Application pending·0 cites
Showing the top 50 of 63 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Avinash Nangia files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →